Quarterly report pursuant to Section 13 or 15(d)

EXERCISE OF CALL OPTIONS OF CURECELL AND ATVIO (Tables)

v3.10.0.1
EXERCISE OF CALL OPTIONS OF CURECELL AND ATVIO (Tables)
9 Months Ended
Aug. 31, 2018
Business Combination, Segment Allocation [Table Text Block]
            CureCell      
           Total assets acquired:      
           Cash and cash equivalents $ 58  
           Property and equipment, net   1,104  
           Inventory   148  
           Other assets   300  
           Other Intangible assets (a)   3,933  
           Goodwill (b)   3,950  
           Total assets   9,493  
       
Total liabilities assumed:      
           Deferred income from the company and others   1,945  
           Deferred tax   80  
           Fair value of convertible loan from the company   892  
           Non-controlling interests   299  
           Other liabilities   1,487  
Total liabilities   4,703  
Total consideration transferred $ 4,790  
       
Fair value according of shares issued   1,853  
Acquisition date fair value of previously held equity interest   2,937  
Total consideration transferred $ 4,790